FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2180463721> ?p ?o ?g. }

• W2180463721 endingPage "118.e6" @default.
• W2180463721 startingPage "118.e1" @default.
• W2180463721 abstract "Introduction Dysfunctional voiding (DV) occurs in neurologically normal children who are not able to establish brain control on detrusor muscle contractions (DMCs). It is also reported to be the result of incorrect voiding habits during toilet training. Children contract pelvic floor muscles (PFMs) to suppress DMC and DV begins. Urinary nerve growth factor (uNGF) is necessary for the synthesis and regulation of neurotransmitters, development of dorsal root ganglia (sensory neurons), and development of sympathetic cells during embryonic and post-natal life. uNGF has also a role in the intracellular signal transduction in nerve cells towards the target organ. To our knowledge, no study has investigated the association between uNGF, biofeedback treatment and DV in children. Objectives The aim was to examine the potential effect of uNGF in the assessment of the effectiveness of biofeedback success in children with lower urinary tract disorders. Study design Fifty-two children with the suspicion of DV and 48 children from a primary school reporting no urinary complaints were enrolled in this study from October 2010 to April 2013 in the Urology Department. uNGF levels were compared. Results The mean uNGF/creatinine (Cr) level was 0.23 ± 0.26 in the control group and 0.96 ± 0.88 in the DV group (p < 0.001). The mean uNGF/Cr levels in the DV group at baseline and at the end of biofeedback therapy at 6 and 12 months were 0.90 ± 0.78, 0.26 ± 0.32, and 0.40 ± 0.50, respectively (p < 0.001) (Figure). Discussion To our knowledge this study is the first to show the correlations between uNGF levels and biofeedback therapy in children with DV. Tissue NGF in 12 patients with overactive bladder (OAB)/detrusor overactivity and 15 healthy women was previously compared and it was suggested that there was no correlation between bladder tissue NGF and OAB. uNGF levels in the bladder in patients with interstitial cystitis and idiopathic sensorial urgency were evaluated previously, and uNGF levels reported. Similar to these reports, most of the previous studies handled uNGF in patients with diseases such as interstitial cystitis, OAB, urinary tract infections, urolithiasis, spinal cord injury, and prostate cancer, and found significantly higher uNGF levels. These studies were generally in adults. A previous study about uNGF comprised 40 children with OAB, in contrast to other studies. According to this study, 40 children diagnosed with OAB were administered anti-muscarinic therapy (oxybutynin 0.3–0.5 mg/kg/day). It was reported that uNGF/Cr levels of the OAB group were higher than control group. In the current study, we evaluated the uNGF difference in DV and the effect of biofeedback treatment on uNGF levels. Conclusions Graphical AbstractThe mean uNGF/Cr levels in the DV group at the baseline, at the end of biofeedback therapy (6 and 12 months). View Large Image Figure Viewer Download Hi-res image" @default.
• W2180463721 created "2016-06-24" @default.
• W2180463721 creator A5020618336 @default.
• W2180463721 creator A5027548452 @default.
• W2180463721 creator A5028290385 @default.
• W2180463721 creator A5034602341 @default.
• W2180463721 creator A5052434725 @default.
• W2180463721 creator A5067332371 @default.
• W2180463721 creator A5072966257 @default.
• W2180463721 creator A5075821678 @default.
• W2180463721 creator A5084357033 @default.
• W2180463721 date "2016-04-01" @default.
• W2180463721 modified "2023-10-15" @default.
• W2180463721 title "The role of urinary nerve growth factor for the diagnosis and assessment of the biofeedback success in children with dysfunctional voiding" @default.
• W2180463721 cites W1495816247 @default.
• W2180463721 cites W1554343522 @default.
• W2180463721 cites W1822032453 @default.
• W2180463721 cites W1981881657 @default.
• W2180463721 cites W1983416314 @default.
• W2180463721 cites W1988689902 @default.
• W2180463721 cites W2004096784 @default.
• W2180463721 cites W2029428280 @default.
• W2180463721 cites W2033847316 @default.
• W2180463721 cites W2042125279 @default.
• W2180463721 cites W2042854422 @default.
• W2180463721 cites W2054473207 @default.
• W2180463721 cites W2074990077 @default.
• W2180463721 cites W2089663469 @default.
• W2180463721 cites W2107309716 @default.
• W2180463721 cites W2127842380 @default.
• W2180463721 cites W2143561995 @default.
• W2180463721 cites W2156727579 @default.
• W2180463721 cites W3196797181 @default.
• W2180463721 doi "https://doi.org/10.1016/j.jpurol.2015.09.015" @default.
• W2180463721 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26701107" @default.
• W2180463721 hasPublicationYear "2016" @default.
• W2180463721 type Work @default.
• W2180463721 sameAs 2180463721 @default.
• W2180463721 citedByCount "9" @default.
• W2180463721 countsByYear W21804637212018 @default.
• W2180463721 countsByYear W21804637212019 @default.
• W2180463721 countsByYear W21804637212020 @default.
• W2180463721 countsByYear W21804637212021 @default.
• W2180463721 countsByYear W21804637212022 @default.
• W2180463721 crossrefType "journal-article" @default.
• W2180463721 hasAuthorship W2180463721A5020618336 @default.
• W2180463721 hasAuthorship W2180463721A5027548452 @default.
• W2180463721 hasAuthorship W2180463721A5028290385 @default.
• W2180463721 hasAuthorship W2180463721A5034602341 @default.
• W2180463721 hasAuthorship W2180463721A5052434725 @default.
• W2180463721 hasAuthorship W2180463721A5067332371 @default.
• W2180463721 hasAuthorship W2180463721A5072966257 @default.
• W2180463721 hasAuthorship W2180463721A5075821678 @default.
• W2180463721 hasAuthorship W2180463721A5084357033 @default.
• W2180463721 hasConcept C121608353 @default.
• W2180463721 hasConcept C126322002 @default.
• W2180463721 hasConcept C126894567 @default.
• W2180463721 hasConcept C141071460 @default.
• W2180463721 hasConcept C170493617 @default.
• W2180463721 hasConcept C1862650 @default.
• W2180463721 hasConcept C27502469 @default.
• W2180463721 hasConcept C2776235491 @default.
• W2180463721 hasConcept C2776377089 @default.
• W2180463721 hasConcept C2778423431 @default.
• W2180463721 hasConcept C2779478474 @default.
• W2180463721 hasConcept C2780616540 @default.
• W2180463721 hasConcept C2781244320 @default.
• W2180463721 hasConcept C2908832260 @default.
• W2180463721 hasConcept C70410870 @default.
• W2180463721 hasConcept C71924100 @default.
• W2180463721 hasConcept C77411442 @default.
• W2180463721 hasConceptScore W2180463721C121608353 @default.
• W2180463721 hasConceptScore W2180463721C126322002 @default.
• W2180463721 hasConceptScore W2180463721C126894567 @default.
• W2180463721 hasConceptScore W2180463721C141071460 @default.
• W2180463721 hasConceptScore W2180463721C170493617 @default.
• W2180463721 hasConceptScore W2180463721C1862650 @default.
• W2180463721 hasConceptScore W2180463721C27502469 @default.
• W2180463721 hasConceptScore W2180463721C2776235491 @default.
• W2180463721 hasConceptScore W2180463721C2776377089 @default.
• W2180463721 hasConceptScore W2180463721C2778423431 @default.
• W2180463721 hasConceptScore W2180463721C2779478474 @default.
• W2180463721 hasConceptScore W2180463721C2780616540 @default.
• W2180463721 hasConceptScore W2180463721C2781244320 @default.
• W2180463721 hasConceptScore W2180463721C2908832260 @default.
• W2180463721 hasConceptScore W2180463721C70410870 @default.
• W2180463721 hasConceptScore W2180463721C71924100 @default.
• W2180463721 hasConceptScore W2180463721C77411442 @default.
• W2180463721 hasIssue "2" @default.
• W2180463721 hasLocation W21804637211 @default.
• W2180463721 hasLocation W21804637212 @default.
• W2180463721 hasOpenAccess W2180463721 @default.
• W2180463721 hasPrimaryLocation W21804637211 @default.
• W2180463721 hasRelatedWork W1975382547 @default.
• W2180463721 hasRelatedWork W1987512841 @default.
• W2180463721 hasRelatedWork W2071264699 @default.
• W2180463721 hasRelatedWork W2079095590 @default.
• W2180463721 hasRelatedWork W2126309436 @default.

• next